See more : Galapagos NV (GLPG) Income Statement Analysis – Financial Results
Complete financial analysis of CareNet, Inc. (2150.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CareNet, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Orkla ASA (ORKLY) Income Statement Analysis – Financial Results
- New Hope Service Holdings Limited (3658.HK) Income Statement Analysis – Financial Results
- Microsoft Corporation (MSF.DE) Income Statement Analysis – Financial Results
- Whitehaven Coal Limited (WHITF) Income Statement Analysis – Financial Results
- Grand Canal Land Public Company Limited (GLAND.BK) Income Statement Analysis – Financial Results
CareNet, Inc. (2150.T)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.carenet.co.jp
About CareNet, Inc.
CareNet, Inc. provides pharmaceutical sales support services for pharmaceutical companies in Japan. It offers medical content services for doctors and healthcare professionals. The company offers CareNet.com, a membership-based medical and medical information site for daily clinical practice; PubMedCLOUD, a tool for searching and managing PubMed articles in Japanese; Doctors'Picks, a site where doctors gather specialized news that they want their doctors to read; CareNeTV, a clinical medicine channel; CareNet DVD, a clinical medical education DVD teaching material; and CareNet Career, a service that guides candidates for work in response to the needs of CareNet members, such as doctors for changing jobs and seeking employment. It also provides MR Plus, a service that distributes medical information from pharmaceutical companies to CareNet doctor members via internet; and Web lecture, a service that live-streams lectures. CareNet, Inc. was incorporated in 1996 and is based in Tokyo, Japan.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 10.24B | 9.33B | 8.00B | 5.30B | 3.27B | 2.90B | 2.85B | 2.20B | 1.91B | 2.20B | 1.80B | 1.77B | 1.59B | 1.63B | 2.17B | 2.65B | 2.62B |
Cost of Revenue | 3.75B | 2.92B | 2.45B | 1.59B | 1.06B | 1.07B | 1.13B | 842.66M | 714.58M | 829.33M | 704.98M | 634.19M | 659.25M | 749.14M | 1.44B | 1.43B | 1.35B |
Gross Profit | 6.49B | 6.41B | 5.56B | 3.71B | 2.21B | 1.83B | 1.72B | 1.35B | 1.20B | 1.37B | 1.09B | 1.13B | 933.93M | 880.07M | 737.68M | 1.22B | 1.26B |
Gross Profit Ratio | 63.40% | 68.74% | 69.45% | 69.98% | 67.48% | 62.97% | 60.27% | 61.64% | 62.63% | 62.30% | 60.77% | 64.11% | 58.62% | 54.02% | 33.93% | 46.01% | 48.23% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 0.00 | 3.51B | 3.02B | 2.17B | 1.60B | 1.36B | 1.31B | 1.16B | 1.04B | 1.12B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Expenses | 4.06B | 3.56B | 3.03B | 2.20B | 1.60B | 1.36B | 5.47M | 785.00K | 1.11M | 0.00 | -13.76M | -12.76M | 4.74M | 1.68M | 491.00K | 209.00K | 794.00K |
Operating Expenses | 4.06B | 3.56B | 3.03B | 2.20B | 1.60B | 1.36B | 1.31B | 1.16B | 1.04B | 1.11B | 1.04B | 1.08B | 1.21B | 1.26B | 878.07M | 1.01B | 860.98M |
Cost & Expenses | 7.81B | 6.48B | 5.47B | 3.79B | 2.66B | 2.43B | 2.45B | 2.00B | 1.76B | 1.94B | 1.74B | 1.72B | 1.87B | 2.01B | 2.31B | 2.44B | 2.22B |
Interest Income | 3.26M | 1.07M | 136.00K | 459.00K | 671.00K | 584.00K | 359.00K | 1.21M | 856.00K | 0.00 | 842.00K | 858.00K | 1.72M | 1.38M | 3.54M | 5.85M | 5.66M |
Interest Expense | 717.00K | 549.00K | 2.15M | 4.64M | 1.25M | 77.00K | 1.49M | 1.91M | 2.16M | 0.00 | 0.00 | 0.00 | 413.50M | 125.57M | 399.90M | 49.46M | 11.78M |
Depreciation & Amortization | 256.17M | 103.89M | 94.64M | 59.58M | 28.46M | 31.24M | 33.99M | 29.76M | 23.77M | 22.67M | 28.17M | 26.88M | 49.69M | 44.82M | 71.62M | 46.36M | 39.98M |
EBITDA | 2.66B | 2.86B | 2.55B | 1.45B | 642.08M | 467.67M | 443.63M | 234.27M | 170.77M | 264.00M | 85.12M | 84.84M | -223.67M | -339.14M | -68.78M | 259.97M | 441.36M |
EBITDA Ratio | 26.02% | 32.28% | 33.19% | 29.71% | 19.52% | 17.39% | 15.54% | 10.45% | 9.04% | 12.00% | 4.74% | 4.22% | -0.88% | -16.87% | 6.13% | 10.86% | 16.86% |
Operating Income | 2.43B | 2.85B | 2.53B | 1.51B | 605.80M | 469.31M | 407.87M | 194.12M | 153.17M | 241.33M | 56.95M | 51.09M | -273.36M | -383.96M | -140.40M | 213.61M | 401.38M |
Operating Income Ratio | 23.73% | 30.57% | 31.64% | 28.47% | 18.53% | 16.17% | 14.29% | 8.84% | 8.01% | 10.97% | 3.17% | 2.89% | -17.16% | -23.57% | -6.46% | 8.06% | 15.34% |
Total Other Income/Expenses | -21.97M | -91.42M | -83.06M | -124.00M | 6.56M | -32.96M | 284.00K | 8.48M | -6.17M | 17.33M | -1.61M | 6.87M | -203.77M | -61.26M | -197.93M | -21.70M | -11.79M |
Income Before Tax | 2.41B | 2.76B | 2.45B | 1.39B | 612.36M | 436.35M | 408.15M | 202.60M | 147.00M | 257.33M | 55.34M | 57.96M | -477.13M | -445.22M | -338.33M | 191.91M | 389.60M |
Income Before Tax Ratio | 23.51% | 29.59% | 30.60% | 26.13% | 18.74% | 15.03% | 14.30% | 9.22% | 7.69% | 11.70% | 3.08% | 3.28% | -29.95% | -27.33% | -15.56% | 7.24% | 14.89% |
Income Tax Expense | 886.18M | 899.54M | 839.49M | 568.20M | 164.47M | 173.07M | -56.27M | 43.55M | 13.05M | 28.00M | 4.68M | 3.22M | 2.50M | 8.28M | 71.44M | 111.37M | -171.40M |
Net Income | 1.51B | 1.85B | 1.61B | 815.59M | 448.01M | 263.46M | 464.43M | 158.54M | 132.24M | 229.33M | 50.66M | 54.75M | -479.63M | -453.49M | -409.77M | 80.54M | 561.00M |
Net Income Ratio | 14.76% | 19.81% | 20.10% | 15.38% | 13.71% | 9.08% | 16.27% | 7.22% | 6.92% | 10.42% | 2.82% | 3.10% | -30.11% | -27.84% | -18.85% | 3.04% | 21.43% |
EPS | 33.90 | 41.70 | 38.11 | 19.64 | 10.58 | 6.12 | 10.74 | 3.66 | 3.06 | 5.31 | 1.22 | 1.32 | -11.53 | -10.82 | -9.81 | 1.93 | 13.53 |
EPS Diluted | 33.90 | 41.70 | 38.11 | 19.64 | 10.58 | 6.12 | 10.74 | 3.65 | 3.05 | 5.29 | 1.20 | 1.29 | -11.53 | -10.82 | -9.81 | 1.86 | 12.63 |
Weighted Avg Shares Out | 44.56M | 44.30M | 42.23M | 41.53M | 42.33M | 43.05M | 43.24M | 43.37M | 43.17M | 43.20M | 41.69M | 41.62M | 41.60M | 41.92M | 41.76M | 41.72M | 41.48M |
Weighted Avg Shares Out (Dil) | 44.56M | 44.30M | 42.23M | 41.53M | 42.33M | 43.05M | 43.24M | 43.41M | 43.39M | 43.32M | 42.26M | 42.48M | 41.60M | 41.92M | 41.76M | 43.30M | 44.42M |
Source: https://incomestatements.info
Category: Stock Reports